India's Panacea Biotec to produce 100 million Sputnik V doses annually: RDIF

Reuters, 05.04.2021

MOSCOW (Reuters) - Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia’s Sputnik V COVID-19 vaccine annually, the RussianDirect Investment Fund (RDIF), which markets the shot internationally, said on Monday.

RDIF did not say when production would begin.